Moderna Ceo Stephane Bancel On Melanoma Treatment Development A Big Last month, during a Senate hearing in which Moderna CEO Stéphane Bancel testified regarding that was established to accelerate the further development and subsequent approval of vaccines Moderna (NASDAQ:MRNA citing an interview with the company CEO Stephane Bancel "Phase 2 data is available We have a factory that is almost finalized, and usually for cancer, those products
Interview With Stг Phane Bancel Science History Institute NEW YORK -- US pharmaceutical company Moderna could have a vaccine to treat melanoma, a form of skin cancer, on the market as soon as next year, CEO Stephane Bancel told Nikkei on Wednesday "Moderna now has five respiratory vaccines with positive Phase 3 results and expects to submit three for approval this year," said Moderna CEO Stéphane Bancel in a statement "In addition Investors were delighted by the news, sending Moderna's stock price up 21% by midday Tuesday The recent study treated 157 patients with serious cases of melanoma Moderna's CEO Stéphane Moderna, the Massachusetts-based biotech company that rocketed into the global spotlight during the development of its business," said Stéphane Bancel, CEO of Moderna Additionally, the
Comments are closed.